Q4 2022 13F Holders as of 31 Dec 2022
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
161,813,505
-
Number of holders
-
333
-
Total 13F shares, excl. options
-
130,693,455
-
Shares change
-
+4,435,022
-
Total reported value, excl. options
-
$4,936,957,475
-
Value change
-
+$160,016,480
-
Put/Call ratio
-
65%
-
Number of buys
-
157
-
Number of sells
-
153
-
Price
-
$37.77
Institutional Holders of Ionis Pharmaceuticals, Inc. - Common Stock (IONS) as of Q4 2022
As of 31 Dec 2022 Ionis Pharmaceuticals, Inc. - Common Stock (IONS) had 333 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 130,693,455 shares of stock of the company.
Largest 10 holders included FMR LLC, VANGUARD GROUP INC, T. Rowe Price Investment Management, Inc., Bellevue Group AG, BlackRock Inc., Clearbridge Investments, LLC, PRICE T ROWE ASSOCIATES INC /MD/, STATE STREET CORP, Tweedy, Browne Co LLC, and ARK Investment Management LLC.
This table shows 333 institutional shareholders of the security as of 31 Dec 2022.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.